BMS and cancer centre settle patent exploitation clash

11-04-2023

Staff writer

BMS and cancer centre settle patent exploitation clash

Feud concerned the ownership of six immunotherapy patents Cancer centre claimed that it was unfairly deprived of royalties.


Dana-Farber Institute, Bristol Myers Squibb, patent, immunotherapy, licensing, Ono Pharmaceutical, patent exploitation, patent ownership, immunotherapy

LSIPR